Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia
Abstract
Share and Cite
Martinez Flores, D.; Akhoundova, D.; Seipel, K.; Legros, M.; Kronig, M.-N.; Daskalakis, M.; Bacher, U.; Pabst, T. Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 2024, 12, 1616. https://doi.org/10.3390/biomedicines12071616
Martinez Flores D, Akhoundova D, Seipel K, Legros M, Kronig M-N, Daskalakis M, Bacher U, Pabst T. Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines. 2024; 12(7):1616. https://doi.org/10.3390/biomedicines12071616
Chicago/Turabian StyleMartinez Flores, Danaë, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Ulrike Bacher, and Thomas Pabst. 2024. "Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia" Biomedicines 12, no. 7: 1616. https://doi.org/10.3390/biomedicines12071616